NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

MUE 03: Management of Urinary Incontinence and Overactive Bladder

Posted: November 09, 2015.
Category - Medicines Update Extra

 Management of Urinary Incontinence and Overactive Bladder

  • Lifestyle interventions and non-pharmacological strategies should be tried as first-line treatment.
  • If pharmacological therapy is indicated, antimuscarinics should be tried first line.
  • Immediate release (IR) oxybutynin, IR and modified release (MR) tolterodine and solifenacin are on the Preferred List of the Formulary.
  • IR oxybutynin and IR tolterodine are significantly less expensive than other preparations on the Formulary, however, they may have less tolerability.
  • MR tolterodine has similar efficacy and tolerability to solifenacin but is significantly less expensive, therefore, consider prescribing MR tolterodine prior to solifenacin.
  • Patients should be reviewed 4 weeks after starting each new therapy and after a dose change.
  • Patients on long term therapy should be reviewed annually or every 6 months if over 75 years.

Read More...

Medicines Update Primary Care October 2015

Posted: October 29, 2015.
Category - Medicines Update Primary Care
Tagged with - Paracetamol Flu Vaccines Paediatrics Corticosteroids

To view this bulletin in PDF format please click here

This bulletin contains information on:

  • Nebuliser -associated Supplies in Primary Care
  • Education on Chronic Pain
  • Flu, Pneumococcal and Shingles Vaccines
  • New Strength Prednisolone Preparations
  • Prophylactic Paracetamol following Meningococcal  Group B Vaccine

Read More...

Community Pharmacy Update October 2015

Posted: October 23, 2015.
Category - Medicines Update Community Pharmacy

The latest edition can be read here. It contains information on: Blood Borne Virus Testing Drug Related Deaths Glut...

Read More...

Prescribing for yourself, friends or family

Posted: October 23, 2015.
Category - Medicines Update
Tagged with - Prescribing

The professional bodies linked to medicine, dentistry, pharmacy, and nursing and midwifery have all issued standards or guidance on prescribing. They all recommend that practitioners should not prescribe for themselves or anyone with whom they ...

Read More...

Yellow Card Roadshow

Posted: October 20, 2015.
Category - Medicines Update

Yellow Card Centre Scotland: Centre for Adverse Reactions to Drugs Scotland (CARDS)   Yellow Card – 50 Years and Counting – What next in its evolution?

Read More...

Formulary Update (Oct 2015)

Posted: October 12, 2015.
Category - Formulary Update

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 19th October. This blog details the Formulary decisions made at that meeting.

Read More...

Heart MCN key messages September 2015

Posted: October 06, 2015.
Category - Medicines Update
Tagged with - Anticoagulants

Primary care education evening on chest pain management The Heart MCN is planning to run primary care education evening in November, focusing on the management of chest pain and acute coronary syndromes, GRASP-AF audi...

Read More...

Blood Glucose Testing

Posted: October 06, 2015.
Category - Medicines Update
Tagged with - Diabetes

The MHRA has issued an alert on potential for incorrect reading wit...

Read More...

PPIs and skin reactions

Posted: October 06, 2015.
Category - Medicines Update

The MHRA Drug Safety Update published in September 2015 highlighted a link between PPIs and very ...

Read More...

LMWH in patients with solid tumours

Posted: October 06, 2015.
Category - Medicines Update
Tagged with - Anticoagulants

SMC have accepted tinzaparin for extended treatment of symptomatic venous thromboembolism and prevention of its recurrence, in patients with solid tumours. NHSGGC specialists advise that dalteparin should remain our LMWH of choice in cancer pat...

Read More...